Breakthrough Technology Proves Rapid Relief of Depression With Non-Invasive Brain Stimulation
Depression, a debilitating disorder affecting millions worldwide, may soon be treatable with an alarmingly effective, non-invasive brain stimulation technology. Researchers from the Department of Psychiatry...
MIRA Pharmaceuticals Achieves 100% Reversal of Neuropathic Pain With Oral Ketamir-2 in Breakthrough Study
Study Highlights Superior Efficacy of Ketamir-2 Over Oral Ketamine, Achieving Full Normalization of Pain ThresholdsMIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a leading pre-clinical-stage pharmaceutical development company, is...
Neurocare Group Receives FDA Clearance for Its Industry-Leading Intermittent Theta Burst Stimulation (iTBS) Protocol for Transcranial Magnetic Stimulation (TMS)
neurocare is pleased to announce that it has received FDA clearance for its industry-leading intermittent Theta Burst Stimulation (iTBS) protocol, available across its Apollo TMS...
MIRA Pharmaceuticals Showcases Significant Progress and Announces Final Phase of Regulatory Work as It Prepares for IND Submission by Year-End
MIRA Pharmaceuticals Inc. (NASDAQ:MIRA) "MIRA" or the "Company"), a leading pre-clinical-stage pharmaceutical company, is pleased to provide a comprehensive update on its recent achievements and...
MIRA Pharmaceuticals Unveils Ketamir-2’s Principal Metabolite: Nor-Ketamir – a Longer-Acting, Brain Penetrating and Selective Compound Acting on the NMDA PCP Receptor
This breakthrough in bioavailability and formulation showcases the potential for advanced, at home neurological treatments.MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), or MIRA Pharmaceuticals, a leading pre-clinical-stage pharmaceutical...
Zoelife Psychiatric Services Receives Prestigious Accreditation for Outpatient Treatment for Adults, Children and Adolescents
Zoelife Psychiatric Services is proud to announce that it has earned a prestigious Three-Year Accreditation from the Commission on Accreditation of Rehabilitation Facilities (CARF) for...
MIRA Pharmaceuticals Announces Positive Discovery of Ketamir-2’s Selective NMDA Binding Mechanism of Action
<p><i><strong>Latest positive preclinical data provides another step in the path to potential IND submission this year for novel ketamine analog</strong></i></p> MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) ("MIRA"...
THIRA Health Welcomes Dr. Al Tsai, MD, as New Medical Director
Thira Health Expands Clinical Expertise With Appointment of Dr. Al Tsai THIRA Health is pleased to announce the appointment of Dr. Al Tsai, MD, as...
OptiMed Introduces a New Service for Treatment-Resistant Depression, Providing Mental Health Support in Munster, Indiana
OptiMed provides SPRAVATO® treatment services to Northwest Indiana and Chicagoland area. OptiMed HealthCare Partners is pleased to announce the opening of its new center in...
Anxiety Canada Breaking Barriers to Mental Health Support
Collaboration with TELUS Health expands access to therapy for people in Canada through exceptional personalized counselling Anxiety Canada, a leading registered charity dedicated to destigmatizing...